Literature DB >> 27334582

Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation.

Zachary L Watson1, Monica K Ertel2, Alfred S Lewin1, Sonal S Tuli3, Gregory S Schultz4, Donna M Neumann5, David C Bloom6.   

Abstract

UNLABELLED: Following infection of epithelial tissues, herpes simplex virus 1 (HSV-1) virions travel via axonal transport to sensory ganglia and establish a lifelong latent infection within neurons. Recent studies have revealed that, following intraganglionic or intrathecal injection, recombinant adeno-associated virus (rAAV) vectors can also infect sensory neurons and are capable of stable, long-term transgene expression. We sought to determine if application of rAAV to peripheral nerve termini at the epithelial surface would allow rAAV to traffic to sensory ganglia in a manner similar to that seen with HSV. We hypothesized that footpad or ocular inoculation with rAAV8 would result in transduction of dorsal root ganglia (DRG) or trigeminal ganglia (TG), respectively. To test this, we inoculated the footpads of mice with various amounts of rAAV as well as rAAV capsid mutants. We demonstrated that this method of inoculation can achieve a transduction rate of >90% of the sensory neurons in the DRG that innervate the footpad. Similarly, we showed that corneal inoculation with rAAV vectors in the rabbit efficiently transduced >70% of the TG neurons in the optic tract. Finally, we demonstrated that coinfection of mouse footpads or rabbit eyes with rAAV vectors and HSV-1 resulted in colocalization in nearly all of the HSV-1-positive neurons. These results suggest that rAAV is a useful tool for the study of HSV-1 infection and may provide a means to deliver therapeutic cargos for the treatment of HSV infections or of dysfunctions of sensory ganglia. IMPORTANCE: Adeno-associated virus (AAV) has been shown to transduce dorsal root ganglion sensory neurons following direct intraganglionic sciatic nerve injection and intraperitoneal and intravenous injection as well as intrathecal injection. We sought to determine if rAAV vectors would be delivered to the same sensory neurons that herpes simplex virus (HSV-1) infects when applied peripherally at an epithelial surface that had been treated to expose the underlying sensory nerve termini. For this study, we chose two well-established HSV-1 infection models: mouse footpad infection and rabbit ocular infection. The results presented here provide the first description of AAV vectors transducing neurons following delivery at the skin/epithelium/eye. The ability of AAV to cotransduce HSV-1-infected neurons in both the mouse and the rabbit provides an opportunity to experimentally explore and disrupt host and viral proteins that are integral to the establishment of HSV-1 latency, to the maintenance of latency, and to reactivation from latency in vivo.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27334582      PMCID: PMC4988153          DOI: 10.1128/JVI.01028-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Seok-Hong Min; Vince Chiodo; Ji-Jing Pang; Li Zhong; Sergei Zolotukhin; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

2.  Gene transfer to dorsal root ganglia by intrathecal injection: effects on regeneration of peripheral nerves.

Authors:  Xu Wang; Chaoyang Wang; Jieming Zeng; Xiaoyun Xu; Peter Y K Hwang; Woon-Chee Yee; Yee-Kong Ng; Shu Wang
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

3.  Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.

Authors:  D M McCarty; P E Monahan; R J Samulski
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

4.  Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle.

Authors:  Chunping Qiao; Wei Zhang; Zhenhua Yuan; Jin-Hong Shin; Jianbin Li; Giridhara R Jayandharan; Li Zhong; Arun Srivastava; Xiao Xiao; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

5.  Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.

Authors:  Carmela Zincarelli; Stephen Soltys; Giuseppe Rengo; Joseph E Rabinowitz
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

6.  Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment.

Authors:  Michael J Castle; Eran Perlson; Erika Lf Holzbaur; John H Wolfe
Journal:  Mol Ther       Date:  2013-10-08       Impact factor: 11.454

7.  A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis.

Authors:  Li Zhong; Weihong Zhao; Jianqing Wu; Baozheng Li; Sergei Zolotukhin; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Mol Ther       Date:  2007-04-17       Impact factor: 11.454

8.  Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins.

Authors:  Jasmina Lovric; Miguel Mano; Lorena Zentilin; Ana Eulalio; Serena Zacchigna; Mauro Giacca
Journal:  Mol Ther       Date:  2012-07-31       Impact factor: 11.454

9.  Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.

Authors:  Christine N Kay; Renee C Ryals; George V Aslanidi; Seok Hong Min; Qing Ruan; Jingfen Sun; Frank M Dyka; Daniel Kasuga; Andrea E Ayala; Kim Van Vliet; Mavis Agbandje-McKenna; William W Hauswirth; Sanford L Boye; Shannon E Boye
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

10.  Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.

Authors:  Dominik F Aschauer; Sebastian Kreuz; Simon Rumpel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more
  7 in total

1.  Depletion of the Insulator Protein CTCF Results in Herpes Simplex Virus 1 Reactivation In Vivo.

Authors:  Shannan D Washington; Samantha I Edenfield; Caroline Lieux; Zachary L Watson; Sean M Taasan; Adit Dhummakupt; David C Bloom; Donna M Neumann
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

2.  In Vivo Knockdown of the Herpes Simplex Virus 1 Latency-Associated Transcript Reduces Reactivation from Latency.

Authors:  Zachary L Watson; Shannan D Washington; Dane M Phelan; Alfred S Lewin; Sonal S Tuli; Gregory S Schultz; Donna M Neumann; David C Bloom
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

3.  Mapping and targeted viral activation of pancreatic nerves in mice reveal their roles in the regulation of glucose metabolism.

Authors:  M Jimenez-Gonzalez; R Li; L E Pomeranz; A Alvarsson; R Marongiu; R F Hampton; M G Kaplitt; R C Vasavada; G J Schwartz; S A Stanley
Journal:  Nat Biomed Eng       Date:  2022-07-14       Impact factor: 29.234

4.  In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia.

Authors:  Chung H Dang; Martine Aubert; Harshana S De Silva Feelixge; Kurt Diem; Michelle A Loprieno; Pavitra Roychoudhury; Daniel Stone; Keith R Jerome
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

Review 5.  Optimization of AAV vectors to target persistent viral reservoirs.

Authors:  Rossana Colón-Thillet; Keith R Jerome; Daniel Stone
Journal:  Virol J       Date:  2021-04-23       Impact factor: 5.913

6.  Intramuscular Delivery of Gene Therapy for Targeting the Nervous System.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2020-07-17       Impact factor: 5.639

7.  Targeting the somatosensory system with AAV9 and AAV2retro viral vectors.

Authors:  Alexander G J Skorput; Reshma Gore; Rachel Schorn; Maureen S Riedl; Ezequiel Marron Fernandez de Velasco; Bailey Hadlich; Kelley F Kitto; Carolyn A Fairbanks; Lucy Vulchanova
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.